A case of anaplastic thyroid cancer treated with lenvatinib and subsequent carotid artery rupture
Author:
Affiliation:
1. Department of Otolaryngology, Head and Neck Surgery, Hyogo Prefectural Amagasaki General Medical Center
2. Department of Cardiovascular Medicine, Hyogo Prefectural Amagasaki General Medical Center
Publisher
Japan Society for Head and Neck Surgery
Link
https://www.jstage.jst.go.jp/article/jjshns/28/2/28_177/_pdf
Reference20 articles.
1. 1）Sugitani I, Miyauchi A, Sugino K, et al: Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patient. World J Surg 36：1247-1254, 2012.
2. 2）松尾美央子：レンバチニブが奏功した甲状腺癌2症例の経験．頭頸部外科，26：259-263，2016．
3. 3）小野田尚佳，徳本真央，野田 諭，他：Lenvatinibを投与した治療抵抗性再発甲状腺未分化癌の1例．日臨外会誌，77 ：291-295，2016.
4. 4）Stjepanovic N, Capdevila J: Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib. Biologics 8：129-139, 2014.
5. 5）Tahara M, Kiyota N, Yamazaki T, et al: Lenvatinib for Anaplastic Thyroid Cancer. Front Oncol 7：25, 2017.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Case of Cooperation and Intervention between Hospital Pharmacists and Community Pharmacists by Pharmaceutical Outpatient Service and Telephone Follow-Up;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3